Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 17, 2025, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Carbamazepine Tablets USP, 200 mg".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 17, 2025, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Carbamazepine Tablets USP, 200 mg".